Depression News and Research

Latest Depression News and Research

Servier, Cortex sign new option agreement for AMPAKINE technology

Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.

13 Jun 2011

Patients with multiple sclerosis can benefit from group therapy sessions

Offering Multiple Sclerosis sufferers emotional support through group therapy sessions could improve their quality of life and save the NHS almost £500 per patient, a study at The University of Nottingham has discovered.

13 Jun 2011

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.

13 Jun 2011

Unique approach improves discharge disposition and older patient's outcomes

The rehospitalization of senior patients within 30 days of discharge from a skilled nursing facility (SNF) has risen dramatically in recent years, at an estimated annual cost of more than $17 billion.

13 Jun 2011

Research Roundup: Depression disparities; Parents' views of vaccines

Archives Of Pediatrics And Adolescent Medicine: Hospital-Based Programs For Children With Special Health Care Needs: Implications Of Health Care Reform -- This study looks at 33 hospital-based comprehensive care programs for children with special needs to evaluate their effectiveness.

10 Jun 2011

GE and Mayo Clinic receive $5.7 million NIH grant to study dedicated MRI brain scanner technology

Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company, and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Neurological Disorders and Stroke (NINDS), components of the National Institutes of Health.

10 Jun 2011

U.S. aid to Afghanistan unlikely to produce lasting change, congressional report says

"Much of the $19 billion in foreign aid that the United States has pumped into Afghanistan in the past decade may be fueling development on the ground in the short term, but is unlikely to produce change that will last once U.S. troops depart, according to a new congressional report," the Christian Science Monitor reports.

10 Jun 2011

Smoking keeps weight off: Study finds out how

The researchers have found that nicotine activates a pathway in the brain that suppresses appetite. The study was published in the journal Science. The authors believe this discovery should lead to better diet drugs.

9 Jun 2011

Social, physical and spiritual activities can improve quality of life in older individuals

Small, healthy lifestyle changes and involvement in meaningful activities-going beyond just diet and exercise-are critical to healthy aging, according to a new USC study.

9 Jun 2011

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.

9 Jun 2011

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.

8 Jun 2011

Articles on health trajectories now available in Nursing Research journal

Health care research typically focuses on final outcomes such as cure or death—overlooking the fact that health and illness are dynamic states that evolve and change over time. A special collection of articles on health trajectory research is now available in a supplement to Nursing Research, official journal of the Eastern Nursing Research Society and the Western Institute of Nursing.

8 Jun 2011

New neurons may take over six months to mature

New neurons take more than six months to mature in adult monkeys and that time is likely even longer in humans, according to researchers at the University of Pittsburgh School of Medicine, the University of Illinois, and Pennsylvania State University.

8 Jun 2011

SPI and Neuralstem sign licensing agreement for major depression drug, NSI-189

Neuralstem, Inc. announced that it has signed an exclusive agency licensing agreement with Summit Pharmaceuticals International Corporation, of Tokyo, Japan (SPI), a wholly owned subsidiary of Sumitomo Corporation Group.

8 Jun 2011

EC approves Biogen Idec's AVONEX PEN to treat multiple sclerosis

Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.

7 Jun 2011

Women with higher leptin levels have fewer symptoms of depression

Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds.

7 Jun 2011

Homelessness and mental illness link explored in RMIT study

In a new study by the RMIT University, Victoria researchers looked at cases of 4,291 people using homelessness services in the city. Dr Guy Johnson and Professor Chris Chamberlain found almost half of them - 46 per cent - lost their homes after a family breakdown. This is contrary to the long held belief that most homeless people are mentally unstable.

7 Jun 2011

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Dr. Reddy's Laboratories today announced that it has launched three products in the US market.

6 Jun 2011

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Ganeden Biotech announced the sale of its leading Sustenex® and Digestive Advantage® brands of probiotic dietary supplements to Schiff Nutrition International, Inc. for $40 million in cash. Ganeden will also receive royalties on Schiff products containing GanedenBC30™.

6 Jun 2011

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Biogen Idec today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.

6 Jun 2011

Depression News and Research

Latest Depression News and Research

Servier, Cortex sign new option agreement for AMPAKINE technology

Patients with multiple sclerosis can benefit from group therapy sessions

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Unique approach improves discharge disposition and older patient's outcomes

Research Roundup: Depression disparities; Parents' views of vaccines

GE and Mayo Clinic receive $5.7 million NIH grant to study dedicated MRI brain scanner technology

U.S. aid to Afghanistan unlikely to produce lasting change, congressional report says

Smoking keeps weight off: Study finds out how

Social, physical and spiritual activities can improve quality of life in older individuals

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Articles on health trajectories now available in Nursing Research journal

New neurons may take over six months to mature

SPI and Neuralstem sign licensing agreement for major depression drug, NSI-189

EC approves Biogen Idec's AVONEX PEN to treat multiple sclerosis

Women with higher leptin levels have fewer symptoms of depression

Homelessness and mental illness link explored in RMIT study

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Depression News and Research

Latest Depression News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in